Lcnb Corp Novartis Ag Transaction History

Lcnb Corp

$275 Million
Q1 2024

A detailed history of Lcnb Corp transactions in Novartis Ag stock. As of the latest transaction made, Lcnb Corp holds 10,809 shares of NVS stock, worth $1.17 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

10,809

Previous 11,384 5.05%

Holding current value

$1.17 Million

Previous $1.15 Million 9.05%

% of portfolio

0.38%

Previous 0.45%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$95.27 - $108.47 $54,780 - $62,370	-575 Reduced 5.05%	10,809 $1.05 Million
Q4 2023 Feb 12, 2024	SELL	$92.27 - $101.54 $16,147 - $17,769	-175 Reduced 1.51%	11,384 $1.15 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $36,471 - $40,475	-385 Reduced 3.22%	11,559 $1.18 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $34,509 - $39,131	373 Added 3.22%	11,944 $1.21 Million
Q1 2023 May 03, 2023	SELL	$80.03 - $92.81 $48,018 - $55,686	-600 Reduced 4.93%	11,571 $1.06 Million

Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $18,887 - $23,130	-250 Reduced 2.01%	12,171 $1.1 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $24,248 - $28,359	-325 Reduced 2.55%	12,421 $944,000
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $39,776 - $46,312	-494 Reduced 3.73%	12,746 $1.08 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $102,941 - $116,446	1,285 Added 10.75%	13,240 $1.16 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $2,470 - $2,732	31 Added 0.26%	11,955 $1.05 Million
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $12,185 - $14,175	-149 Reduced 1.23%	11,924 $975,000
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $9,717 - $10,733	-114 Reduced 0.94%	12,073 $1.1 Million
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $31,227 - $37,772	-400 Reduced 3.18%	12,187 $1.15 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $23,984 - $26,572	-292 Reduced 2.27%	12,587 $1.1 Million
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $28,649 - $32,249	354 Added 2.83%	12,879 $1.13 Million
Q1 2020 May 11, 2020	SELL	$70.67 - $99.01 $5,300 - $7,425	-75 Reduced 0.6%	12,525 $1.03 Million
Q4 2019 Feb 10, 2020	SELL	$84.35 - $95.37 $35,848 - $40,532	-425 Reduced 3.26%	12,600 $1.19 Million
Q3 2019 Nov 08, 2019	BUY	$85.54 - $94.26 $34,900 - $38,458	408 Added 3.23%	13,025 $1.13 Million
Q2 2019 Aug 01, 2019	SELL	$75.4 - $92.8 $161,808 - $199,148	-2,146 Reduced 14.54%	12,617 $1.15 Million
Q1 2019 May 02, 2019	SELL	$75.32 - $86.15 $21,918 - $25,069	-291 Reduced 1.93%	14,763 $1.42 Million
Q3 2018 Nov 09, 2018	SELL	$66.94 - $77.43 $35,478 - $41,037	-530 Reduced 3.4%	15,054 $1.3 Million
Q2 2018 Aug 13, 2018	BUY	$64.91 - $73.36 $123,718 - $139,824	1,906 Added 13.93%	15,584 $1.18 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $17,104 - $20,448	-243 Reduced 1.75%	13,678 $1.11 Million
Q4 2017 Feb 13, 2018	SELL	$72.33 - $77.64 $8,317 - $8,928	-115 Reduced 0.82%	13,921 $1.17 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $1,927 - $2,009	26 Added 0.19%	14,036 $1.21 Million
Q2 2017 Aug 14, 2017	BUY	N/A	14,010	14,010 $1.17 Million

Others Institutions Holding NVS

# of Institutions

1,350

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $233B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.

Account